OTC:INLB

Item 9 Labs (INLB) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
12,581 shs
Average Volume
16.59 million shs
Market Capitalization
$70,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
INLB stock logo

About Item 9 Labs Stock (OTC:INLB)

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

INLB Stock News Headlines

Item 9 Labs Corp
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
INLB Item 9 Labs Corp.
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Noble Financial Keeps Their Hold Rating on Item 9 Labs (INLB)
See More Headlines
Receive INLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Item 9 Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/16/2022
Today
4/25/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
97
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$21.76 million
Book Value
$0.65 per share

Miscellaneous

Free Float
N/A
Market Cap
$70,000.00
Optionable
Not Optionable
Beta
0.80
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Robert E. Mikkelsen (Age 42)
    Secretary, Treasurer & CFO
    Comp: $263.68k
  • Mr. Christopher Leland Wolven (Age 41)
    Chief Operating Officer
    Comp: $256.45k
  • Mr. Jeffrey I. Rassas (Age 61)
    Strategic Advisor & Director
    Comp: $176.58k
  • Ms. Jayne Levy
    Senior Vice President of Communications
  • Kyle Jennings
    Vice President of Marketing
  • Mr. Mark Busch
    Senior Vice President of Corporate Development
  • Mr. Cory Carter
    Senior Vice President of Cultivation

INLB Stock Analysis - Frequently Asked Questions

When is Item 9 Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our INLB earnings forecast
.

How were Item 9 Labs' earnings last quarter?

Item 9 Labs Corp. (OTC:INLB) announced its quarterly earnings results on Monday, May, 16th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01.

How do I buy shares of Item 9 Labs?

Shares of INLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTC:INLB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners